The Scientific Observer Issue 26

Over the last six years, three anti-amyloid immunotherapies have emerged to tackle Alzheimer’s disease – but they have been met with skepticism by some members of the scientific community. This month's feature article explores why the field is so divided and how this might inhibit our quest towards a cure. 

We’re also diving into the controversies surrounding the body mass index (BMI) measure, the impact of synthetic biology on modern medicine and critical advances in cancer diagnostics. 

This, and much more in issue 26. Download your copy now to also receive an exclusive infographic:  Cell Signaling in the Brain.   

Issue 26 highlights:  

Neurodegeneration: Are We Closer to a Cure, or Still a World Apart?

Time To Say Goodbye to the Traditional BMI

A Recipe for Richer Metabolomics